Rongfeng XIANG, Qing DAI, Yan ZHOU, et al. Determination of ginsenoside Rg3 in rat plasma using high-performance liquid chromatography-tandem mass spectrometry[J]. Journal of Third Military Medical University, 2018, 40(12): 1073-1078.
DOI:
Rongfeng XIANG, Qing DAI, Yan ZHOU, et al. Determination of ginsenoside Rg3 in rat plasma using high-performance liquid chromatography-tandem mass spectrometry[J]. Journal of Third Military Medical University, 2018, 40(12): 1073-1078. DOI: 10.16016/j.1000-5404.201712007.
Determination of ginsenoside Rg3 in rat plasma using high-performance liquid chromatography-tandem mass spectrometry
To establish a high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) system for determination of ginsenoside Rg3 content in rat plasma.
Methods
2
Venous blood samples were collected from the orbit of 6 rats at different time points after intragastric administration of 20 mg/kg ginsenosides Rg3. Plasma was isolated and the samples were extracted with ethyl acetate
followed by chromatographic separation using a C18 column (2.1 mm×50 mm
5μm) with acetonitrile-ammonium acetate (10 mmol/L
containing 0.1% formic acid) (90 :10) as the mobile phase at a flow rate 0.4 mL/min. The detection was accomplished with the electrospray ionization source operated in the negative ionization mode. The pharmacokinetic parameters were computed using DAS 3.3.1 pharmacokinetic software.
Results
2
The linear calibration curves of ginsenoside Rg3 in rat plasma were obtained within the concentration range of 2~400 ng/mL. The inter- and intra-batch RSDs and the matrix effect of ginsenoside Rg3 detection were all below 15%. Analysis of the pharmacokinetic parameters showed that in rats
ginsenoside Rg3 had an AUC
0-t
of 821.659±170.125 ng·h/mL
an AUC
0-∞
of 912.468±190.653 ng·h/mL
a
C
max
of 138.803±28.997 ng/mL
and a
t
1/2
of 2.803±0.263 h.
Conclusion
2
This HPLC-MS/MS system allows rapid
sensitive and accurate determination of ginsenoside Rg3 in rat plasma.
LI Y, ZHANG T J, LIU S X, et al . Research progress in chemical constituents and pharmacological activities of Panax ginseng[J ] . Chin Tradit Herb Drugs, 2009, 40(1): 164-166.
WANG J L, KONG P Y, XU W, et al . Ginsenosisde Rg3 inhibits HIF-1α and VEGF expressions in acute leukemia bone marrow stromal cells[J ] . J Third Mil Med Univ, 2010, 32(07): 621-624.
HE F, SUN X L, SU Y L, et al . Pharmacokinetics of ginsenoside Rg3 and its main metabolite in rats determined[J ] .?Pharmacol Clin Chin Materia Medica, 2015, 31(4): 14-16.
JIANG C, MIAO Y Q, ZHOU W L, et al . Research progress of ginsenoside Rg3 in anticancer activitie s[J ] . Chin Clin Oncol, DOI: 10.3969/j.issn.1009- 0460.2017.07.019.
MOHANAN P, SUBRAMANIYAM S, MATHIYALAGAN R, et al . The molecular signaling of ginsenosides Rb1, Rg1, Rg3 and their mode of actions[J ] . J Ginseng Res, 2017(1-10). DOI:org/10.1016/j.jgr.2017.01.008.
LIU J H, LU D, LIU J P, et al . Studies on pharmacokinetics of 20(S)-Ginsenoside Rg3 after intramuscular administration to rats[J ] . Chin Pharm J, 2007, 42(14): 1087-1090. DOI: 10.3321/j.issn: 1001-2494.2007.14.013.
PENG M, LI X, ZHANG T, et al . Stereoselective pharmacokinetic and metabolism studies of 20(S)- and 20(R)-ginsenoside Rg epimers in rat plasma by liquid chromatography-electrospray ionization mass spectrometry[J ] . J Pharm Biomed Anal, 2016, 121: 215-224. DOI: 10.1016/j.jpba.2016.01.020.
XIE H T, WANG G J, SUN J G, et al . High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies[J ] . J Chromatogr B, 2005, 818(2): 167-173. DOI: 10.1016/j.jchromb.2004.12.028.
LI K, CHEN X, XU J, et al . Liquid chromatography/tandem mass spectrometry for pharmacokinetic studies of 20(R)-ginsenoside Rg3 in dog[J ] . Rapid Commun Mass Spectrom, 2005, 19(6): 813-817. DOI: 10.1002/rcm.1862.
PANG H, WANG H L, FU L, et al . Pharmaco- kinetics studies of 20(R)- Ginsenoside Rg3 in human volunteers[J ] . Acta Pharm Sin, 2001, 36(3): 170-173. DOI: 10.16438/j.0513-4870.2001.03.003.
ZHAO Q, ZHENG X, JIANG J, et al . Determination of ginsenoside Rg3 in human plasma and urine by high performance liquid chromatography-tandem mass spectrometry[J ] . J Chromatogr B, 2010, 878(24): 2266-2273. DOI: 10.1016/j.jchromb.2010.06.019.
KANG A, QIAN J, SHAN J J, et al . In vivo pharmacokinetic study on total saponins from roots of panax ginseng in rats[J ] . Chin Tradit Herb Drugs, 2015, 46(20): 3045-3050. DOI: 10.7501/j.issn. 0253-2670.2015.20.014..
LIU Y R, SHI X B, CHEN Y Q, et al . Simultaneous determination of 15 ginsenosides from panacis majoris rhizoma by HPLC-ESI-MS/MS method[J ] . Chin Tradit Herb Drugs, 2016, 47(19): 3502-3507. DOI: 10. 7501/j.issn.0253-2670.2016.19.024.
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China[M]. 2015 Ed, Beijing: Chinese Medicine Science and Technology Press, 2015: 363-368.